Soleno Therapeutics Inc

NASDAQ:SLNO  
1.06
-0.01 (-0.94%)
Products

Soleno Therapeutics Receives Orphan Drug Designation From FDA For Diazoxide Choline For The Treatment Of Glycogen Storage Disease Type 1A

Published: 06/02/2021 12:35 GMT
Soleno Therapeutics Inc (SLNO) - Soleno Therapeutics Receives Orphan Drug Designation From FDA for Diazoxide Choline for the Treatment of Glycogen Storage Disease Type 1a.